Application

17821035 · METHODS OF TREATING NEUROFIBROMATOSIS TYPE 1 WITH N-((R))-2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2-FLUORO-4-IODOPHENYLAMINO)-BENZAMIDE

Filed 2022-08-19 · Granted · Patent 12037306 (2024-07-16) The official file ↗The patent and its PDF ↗ · Art unit 1629 · Examiner Raymond J Henley III Easy · CPC C07C 237/28 · Warner-Lambert Company LLC · SpringWorks Therapeutics / BLANK ROME LLP

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

16.9 mo

to disposition 22.9 mo

Statutes raised

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.